About this episode
How the STEP-UP trial came to life, and what made the 7.2mg dose possible
What the data actually says about weight loss and side effects at higher doses
Why trial design, pharmacokinetics, and estimands matter more than you think
What’s coming next in obesity meds: duals, triples, and even antagonists
The real talk on intermittent fasting, access issues, and preaching vs. science
Sign up for Dr. Spencer''s Clinic
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Docs Who Lift publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Docs Who Lift
Does Metabolically Healthy Obesity Even Exist?
Docs Who Lift
Is Your Obesity Genetic? Food Noise and Bardet-Biedl Syndrome Explained
Docs Who Lift
PCOS Renamed to PMOS? Here's Why and What Changes for You
Docs Who Lift
Are Peptides the New Snake Oil? What the Actual Science Says With Barbell Medici...
Docs Who Lift